Botulinum toxin blocks comprising the Neuronox ® binder accept neuromuscular transmission sites on motor nerve endings, are used in nerve endings, and prevent the release of acetylcholine.
This inhibition occurs while the neurotoxin cleaves SNAP-25, an integral protein of successful docking and release of acetylcholine from vesicles in the nerve endings.
Once injected intramuscularly at therapeutic doses, Neuronox ® produces partial chemical denervation of the muscle, resulting in a localized reduction in muscle activity.
Mainly used as a global botulinum toxin type A anti-wrinkle, they have been used for various indications such as hemifascial spasm, cervical dystonia and blepharospam. All clients who have ever used Neuronox are absolutely satisfied with Neuronox.